IGC IGC Pharma, Inc.

NYSE igcpharma.com


$ 0.41 $ 0.02 (5.96 %)    

Tuesday, 14-Oct-2025 19:49:43 EDT
QQQ $ 598.50 $ -4.01 (-0.67 %)
DIA $ 463.08 $ 2.03 (0.44 %)
SPY $ 662.74 $ -0.81 (-0.12 %)
TLT $ 90.69 $ 0.29 (0.32 %)
GLD $ 382.95 $ 2.70 (0.71 %)
$ 0.4163
$ 0.41
$ 0.38 x 500
$ 0.42 x 500
$ 0.39 - $ 0.42
$ 0.25 - $ 0.50
1,194,040
na
34.56M
$ 1.00
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 06-27-2025 03-31-2025 10-K
3 02-14-2025 12-31-2024 10-Q
4 11-12-2024 09-30-2024 10-Q
5 08-07-2024 06-30-2024 10-Q
6 06-24-2024 03-31-2024 10-K
7 02-14-2024 12-31-2023 10-Q
8 11-09-2023 09-30-2023 10-Q
9 08-10-2023 06-30-2023 10-Q
10 07-07-2023 03-31-2023 10-K
11 02-14-2023 12-31-2022 10-Q
12 11-01-2022 09-30-2022 10-Q
13 08-05-2022 06-30-2022 10-Q
14 06-22-2022 03-31-2022 10-K
15 02-10-2022 12-31-2021 10-Q
16 10-29-2021 09-30-2021 10-Q
17 08-11-2021 06-30-2021 10-Q
18 06-14-2021 03-31-2021 10-K
19 02-16-2021 12-31-2020 10-Q
20 11-20-2020 09-30-2020 10-Q
21 08-19-2020 06-30-2020 10-Q
22 07-13-2020 03-31-2020 10-K
23 02-10-2020 12-31-2019 10-Q
24 11-06-2019 09-30-2019 10-Q
25 08-09-2019 06-30-2019 10-Q
26 06-14-2019 03-31-2019 10-K
27 02-12-2019 12-31-2018 10-Q
28 10-16-2018 09-30-2018 10-Q
29 08-03-2018 06-30-2018 10-Q
30 06-21-2018 03-31-2018 10-K
31 02-20-2018 12-31-2017 10-Q
32 11-17-2017 09-30-2017 10-Q
33 08-18-2017 06-30-2017 10-Q
34 07-14-2017 03-31-2017 10-K
35 02-21-2017 12-31-2016 10-Q
36 11-21-2016 09-30-2016 10-Q
37 08-16-2016 06-30-2016 10-Q
38 07-14-2016 03-31-2016 10-K
39 02-16-2016 12-31-2015 10-Q
40 11-13-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 igc-pharma-expands-ongoing-phase-2-calma-clinical-trial-evaluating-investigational-drug-candidate-igc-ad1-for-agitation-in-alzheimers-disease

IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE:IGC), a clinical-stage biotechnology com...

 igc-pharma-unit-enters-sale-of-assets-agreement-for-27m

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001326205/000118518525001326/igc8k100125.htm

 igc-pharma-adds-new-clinical-trial-site-to-ongoing-phase-2-study-evaluating-igc-ad1-investigational-drug-candidate-for-treating-agitation-in-alzheimers-disease

IGC Pharma, Inc. (NYSE: IGC) today announced the addition of a new clinical trial site to its ongoing Phase 2 study evaluating ...

 igc-pharma-releases-preclinical-data-on-tgr-63-showing-it-impacts-beta-amyloid-pathology-and-inhibits-tau-protein-aggregation-addressing-two-hallmarks-of-alzheimers-disease

IGC Pharma, Inc. (NYSE:IGC) today announced preclinical findings on TGR-63, the Company's investigational small-molecule ca...

 igc-pharma-reports-tgr-63-blocks-both-amyloid-and-tau-aggregation-in-alzheimers-advances-dual-action-therapy-approach

IGC Pharma, Inc. (NYSE:IGC) today announced preclinical findings on TGR-63, the Company's investigational small-molecule ca...

Core News & Articles

https://www.gov.ca.gov/2025/09/22/governor-newsom-signs-legislation-cutting-taxes-on-cannabis-promoting-the-long-term-success-o...

Core News & Articles

https://www.marijuanamoment.net/marijuana-industry-group-pushes-congress-for-tax-relief-and-to-apply-the-fix-retroactively-for-...

Core News & Articles

https://www.marijuanamoment.net/trumps-drug-czar-pick-says-marijuana-is-a-bipartisan-issue-but-admin-still-exploring-all-option...

Core News & Articles

https://x.com/AMartinelliWA/status/1966198351692763194

 ascendiant-capital-maintains-buy-on-igc-pharma-raises-price-target-to-45

Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the price target from $4.25 to $...

 igc-pharma-announces-expansion-of-its-ongoing-phase-2-clinical-trial-evaluating-igc-ad1-for-treating-agitation-in-patients-with-alzheimers-disease

IGC Pharma, Inc. (NYSE:IGC) today announced the expansion of its ongoing Phase 2 clinical trial evaluating IGC-AD1, an investig...

Core News & Articles

https://www.marijuanamoment.net/new-republican-national-committee-chairman-supports-marijuana-legalization/

Core News & Articles

https://themarijuanaherald.com/2025/08/staffers-cannabis/

 igc-pharma-q1-eps-002-beats-003-estimate-sales-328000k-beat-326000k-estimate

IGC Pharma (AMEX:IGC) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.03) by 20...

Core News & Articles

https://www.marijuanamoment.net/key-voices-in-trumps-maga-movement-are-divided-on-marijuana-as-president-considers-rescheduling...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION